Alaunos Therapeutics reported $666K in Current Assets for its fiscal quarter ending in June of 2026.





Current Assets Change Date
Alaunos Therapeutics USD 666K 304K Jun/2026
Amgen USD 34.36B 598M Sep/2026
AstraZeneca USD 31.45B 3.48B Sep/2026
Baxter International USD 6.83B 163M Sep/2026
Biogen USD 7.58B 278.7M Sep/2026
Bioline Rx USD 16.35M 5.23M Jun/2026
Bristol-Myers Squibb USD 29.77B 1.19B Sep/2026
Celltrion KRW 493.66B 12.09B Jun/2026
Corcept Therapeutics USD 533.87M 94.2M Sep/2026
Cspc Pharmaceutical CNY 22.25B 359.48M Dec/2025
Curis USD 16.61M 9.7M Mar/2026
Deva Holding AS TRY 9.13B 1.61B Sep/2023
Dianthus Therapeutics USD 856.04M 41.5M Sep/2026
Divis Laboratories Ltd INR 124.39B 13.43B Sep/2026
Gilead Sciences USD 16.55B 4.02B Sep/2026
GlaxoSmithKline GBP 17.9B 336M Sep/2026
Incyte USD 5.52B 505.2M Sep/2026
Intrexon USD 23.72M 45.04M Jun/2024
Ionis Pharmaceuticals USD 2.36B 129.77M Sep/2026
J&J USD 56.35B 3.42B Sep/2026
Kangmei Pharma CNY 6.66B 143.43M Jun/2026
Karyopharm Therapeutics USD 126.33M 23.19M Mar/2026
Knight Therapeutics CAD 394.84M 5.86M Dec/2025
Laboratorios Farma EUR 509.33M 128.63M Dec/2023
Malin Corporation EUR 62.6M 26.7M Dec/2024
Medical Developments International AUD 33.75M 1.79M Dec/2025
Merck USD 38.94B 2.26B Sep/2026
Neuren Pharmaceuticals AUD 332.23M 11.98M Dec/2025
Novartis USD 28.75B 1.4B Sep/2026
Organigram Holdings CAD 280.09M 30M Jun/2026
Ovoca Bio EUR 2.07M 510K Dec/2025
Pfizer USD 45.01B 3.65B Sep/2026
Pharma Mar EUR 295.56M 14.62M Sep/2026
PTC Therapeutics USD 2.54B 79.58M Sep/2026
Qiagen NV USD 1.66B 116.37M Jun/2026
Regeneron Pharmaceuticals USD 20.8B 2.35B Sep/2026
Roche Holding CHF 35.44B 3.29B Jun/2026
Sangamo BioSciences USD 49.89M 12.3M Jun/2025
Sartorius EUR 1.65B 8.4M Sep/2026
Sino Biopharmaceutical CNY 33.82B 9.13B Jun/2025
TG Therapeutics USD 1.17B 25.76M Sep/2026
Tilray USD 729.32M 28.18M Sep/2025
Verastem USD 202.9M 20.51M Mar/2026
Zealand Pharma A/S 15.02B 652.12M Mar/2026
Zz Pientze Pharmaceu CNY 13.48B 2.32B Sep/2026